The use of botulinum toxin A is a relatively new and innovative therapeutic intervention for children with cerebral palsy. The purpose of this review is to summarize nine articles, all published since 1993, that relate specifically to the use of botulinum toxin A in the management of spasticity in children with cerebral palsy. A range of outcome measures were employed in these studies including assessment of muscle tone, range of motion, appearance, gait analysis, gross or fine motor functional status, and parent or guardian questionnaire. In general, the findings demonstrated significant improvements, especially in muscle tone, range of motion, and functional motor status.